Sex differences and rehabilitation needs after hospital discharge for COVID-19: an Italian cross-sectional study.
COVID-19
rehabilitation medicine
respiratory infections
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
18 05 2022
18 05 2022
Historique:
entrez:
18
5
2022
pubmed:
19
5
2022
medline:
21
5
2022
Statut:
epublish
Résumé
COVID-19 can result in persistent symptoms leaving potential rehabilitation needs unmet. This study aims to describe persistent symptoms and health status of individuals hospitalised for COVID-19 according to the International Classification of Functioning, Disability and Health domains of impairments, limitations in activity, and participation restrictions. Cross-sectional study consisting in a telephone interview 3 months after hospital discharge. This study was conducted during the first peak of the COVID-19 pandemic by the Local Health Authority of Reggio Emilia (Italy). Adult individuals discharged from hospital between April and June 2020 after COVID-19. hospitalisation for reasons other than COVID-19, inability to participate in the study, concomitant acute or chronic conditions causing disability. We assessed: dyspnoea (Medical Research Council), fatigue (Fatigue Severity Scale), mood disturbances (Hospital Anxiety and Depression Scale), limitations in activity (Barthel Index) and participation restrictions (Reintegration to Normal Living Index). We also collected data on sociodemographic characteristics, health status prior to COVID-19, COVID-related clinical manifestations and hospital care pathway up to discharge, rehabilitation interventions, accidental falls and emergency room access. 149 participants (men, 62%; average age 62 (±11) years) were enrolled, 35 of which (23%) were admitted to the intensive care unit (ICU) while hospitalised. Three months after hospital discharge, nearly half of the participants still suffered from dyspnoea (44%) or fatigue (39%). Almost all individuals (91.2%) recovered a good level of independence in activity of daily living, but 76% still suffered participation restrictions. Female sex was significantly associated with worse outcomes for all symptoms. Individuals who had moderate or severe COVID-19 may perceive persistent symptoms which may result in reduced social participation. Sex differences should be monitored, as women may recover more slowly than men. NCT04438239.
Identifiants
pubmed: 35584875
pii: bmjopen-2021-055308
doi: 10.1136/bmjopen-2021-055308
pmc: PMC9118361
doi:
Banques de données
ClinicalTrials.gov
['NCT04438239']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e055308Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Cureus. 2021 Feb 2;13(2):e13080
pubmed: 33680620
Thorax. 1999 Jul;54(7):581-6
pubmed: 10377201
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
SN Compr Clin Med. 2021;3(2):419-436
pubmed: 33521564
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Clin Infect Dis. 2021 Sep 7;73(5):e1089-e1098
pubmed: 33220049
Cureus. 2020 Aug 29;12(8):e10114
pubmed: 33005531
PM R. 2020 May;12(5):512-515
pubmed: 32196983
Int J Environ Res Public Health. 2021 Jan 04;18(1):
pubmed: 33406588
Front Neuroendocrinol. 2014 Aug;35(3):347-69
pubmed: 24793874
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910
BMJ. 2021 Jan 22;372:n136
pubmed: 33483331
Biol Sex Differ. 2020 Oct 16;11(1):57
pubmed: 33066823
Heart Lung. 2020 Nov - Dec;49(6):883-884
pubmed: 32690219
PLoS One. 2020 Nov 9;15(11):e0240784
pubmed: 33166287
Eur J Phys Rehabil Med. 2020 Jun;56(3):316-318
pubmed: 32175719
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Apr 12;43(4):308-314
pubmed: 32294814
Soc Psychiatry Psychiatr Epidemiol. 2006 Nov;41(11):853-61
pubmed: 16915360
Ann Intern Med. 2020 Sep 1;173(5):385-386
pubmed: 32384135
Arch Neurol. 1989 Oct;46(10):1121-3
pubmed: 2803071
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Lancet. 2020 Mar 14;395(10227):846-848
pubmed: 32151325
J Physiother. 2020 Apr;66(2):73-82
pubmed: 32312646
JAMA. 2021 Apr 20;325(15):1525-1534
pubmed: 33729425
J Occup Med Toxicol. 2021 Oct 07;16(1):45
pubmed: 34620202
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
JAMA. 2021 May 25;325(20):2036-2037
pubmed: 33950195
PLoS One. 2021 Dec 7;16(12):e0260568
pubmed: 34874962